FRESENIUS MEDICAL CARE AG Adjustments For Depreciation And Amortisation Expense
FRESENIUS MEDICAL CARE AG (FMCQF) reported Adjustments For Depreciation And Amortisation Expense of EUR 1.16 billion for the 9-month period ending 2019-09-30, per its 6-K filed 2019-10-31.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2019-10-31
- FRESENIUS MEDICAL CARE AG adjustments for depreciation and amortisation expense for the quarter ending 2019-09-30 was 409.29M EUR, a 128.93% increase year-over-year.
- FRESENIUS MEDICAL CARE AG adjustments for depreciation and amortisation expense for the quarter ending 2019-06-30 was 387.00M EUR, a 114.71% increase year-over-year.
- FRESENIUS MEDICAL CARE AG adjustments for depreciation and amortisation expense for the quarter ending 2019-03-31 was 362.38M EUR, a 107.08% increase year-over-year.
- FRESENIUS MEDICAL CARE AG adjustments for depreciation and amortisation expense for the quarter ending 2018-12-31 was 190.83M EUR, a 5.02% increase year-over-year.
| Period end | Adjustments For Depreciation And Amortisation Expense 3 month | Adjustments For Depreciation And Amortisation Expense 6 month | Adjustments For Depreciation And Amortisation Expense 9 month | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | 409.29M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 796.29M EUR derived: sum of 2 quarters · filed 2019-10-31 | 1.16B EUR 6-K · filed 2019-10-31 | 1.35B EUR derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 387.00M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | 749.38M EUR 6-K · filed 2019-07-30 | 940.21M EUR derived: sum of 3 quarters · filed 2019-07-30 | 1.12B EUR derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | 362.38M EUR 6-K · filed 2019-05-02 | 553.21M EUR derived: sum of 2 quarters · filed 2019-05-02 | 731.99M EUR derived: sum of 3 quarters · filed 2019-10-31 | 912.23M EUR derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-12-31 | 190.83M EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-02-20 | 369.61M EUR derived: sum of 2 quarters · filed 2019-10-31 | 549.85M EUR derived: sum of 3 quarters · filed 2019-10-31 | 724.85M EUR 20-F · filed 2019-02-20 |
| 2018-09-30 | 178.78M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 359.02M EUR derived: sum of 2 quarters · filed 2019-10-31 | 534.02M EUR 6-K · filed 2019-10-31 | 715.73M EUR derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | 180.24M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | 355.24M EUR 6-K · filed 2019-07-30 | 536.95M EUR derived: sum of 3 quarters · filed 2019-07-30 | 714.73M EUR derived: sum of 4 quarters · filed 2019-07-30 |
| 2018-03-31 | 174.99M EUR 6-K · filed 2019-05-02 | 356.71M EUR derived: sum of 2 quarters · filed 2019-05-02 | 534.49M EUR derived: sum of 3 quarters · filed 2019-05-02 | 720.57M EUR derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | 181.72M EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-02-20 | 359.50M EUR derived: sum of 2 quarters · filed 2019-02-20 | 545.57M EUR derived: sum of 3 quarters · filed 2019-02-20 | 735.48M EUR 20-F · filed 2019-02-20 |
| 2017-09-30 | 177.78M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-10-30 | 363.86M EUR derived: sum of 2 quarters · filed 2018-10-30 | 553.76M EUR 6-K · filed 2018-10-30 | |
| 2017-06-30 | 186.07M EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-01 | 375.98M EUR 6-K · filed 2018-08-01 | ||
| 2017-03-31 | 189.91M EUR 6-K · filed 2018-05-03 | |||
| 2016-12-31 | 701.54M EUR 20-F · filed 2019-02-20 | |||
| 2015-12-31 | 648.17M EUR 20-F · filed 2018-02-27 |